{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:21Z","timestamp":1707524961591},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,30]]},"DOI":"10.7759\/cureus.36925","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T22:55:41Z","timestamp":1680216941000},"source":"Crossref","is-referenced-by-count":0,"title":["Intractable Pleural Effusion After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer"],"prefix":"10.7759","author":[{"given":"Atsuto","family":"Katano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanari","family":"Minamitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Nozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideomi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang JY","year":"2021","unstructured":"Chang JY, Mehran RJ, Feng L, et al.. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery. Lancet Oncol. 2021, 22:1448-57. 10.1016\/S1470-2045(21)00401-0","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202203-275OC","article-title":"Adverse events following limited resection versus stereotactic body radiation therapy for early stage lung cancer","volume":"19","author":"Wang Q","year":"2022","unstructured":"Wang Q, Stone K, Kern JA, et al.. Adverse events following limited resection versus stereotactic body radiation therapy for early stage lung cancer. Ann Am Thorac Soc. 2022, 19:2053-61. 10.1513\/AnnalsATS.202203-275OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman R","year":"2010","unstructured":"Timmerman R, Paulus R, Galvin J, et al.. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010, 303:1070-6. 10.1001\/jama.2010.261","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061561","article-title":"Radiation-induced lung fibrosis: preclinical animal models and therapeutic strategies","volume":"12","author":"Jin H","year":"2020","unstructured":"Jin H, Yoo Y, Kim Y, Kim Y, Cho J, Lee YS. Radiation-induced lung fibrosis: preclinical animal models and therapeutic strategies. Cancers (Basel). 2020, 12:1561. 10.3390\/cancers12061561","journal-title":"Cancers (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-020-01654-9","article-title":"Radiation-induced lung toxicity - cellular and molecular mechanisms of pathogenesis, management, and literature review","volume":"15","author":"K\u00e4smann L","year":"2020","unstructured":"K\u00e4smann L, Dietrich A, Staab-Weijnitz CA, et al.. Radiation-induced lung toxicity - cellular and molecular mechanisms of pathogenesis, management, and literature review. Radiat Oncol. 2020, 15:214. 10.1186\/s13014-020-01654-9","journal-title":"Radiat Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18824","article-title":"Thoracic radiation-induced pleural effusion and risk factors in patients with lung cancer","volume":"8","author":"Zhao J","year":"2017","unstructured":"Zhao J, Day RM, Jin JY, et al.. Thoracic radiation-induced pleural effusion and risk factors in patients with lung cancer. Oncotarget. 2017, 8:97623-32. 10.18632\/oncotarget.18824","journal-title":"Oncotarget"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2016.01.015","article-title":"Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy","volume":"6","author":"Harder EM","year":"2016","unstructured":"Harder EM, Park HS, Chen ZJ, Decker RH. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy. Pract Radiat Oncol. 2016, 6:e353-9. 10.1016\/j.prro.2016.01.015","journal-title":"Pract Radiat Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00877","article-title":"Radiation-induced lung injury (RILI)","volume":"9","author":"Giuranno L","year":"2019","unstructured":"Giuranno L, Ient J, De Ruysscher D, Vooijs MA. Radiation-induced lung injury (RILI). Front Oncol. 2019, 9:877. 10.3389\/fonc.2019.00877","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.03.033","article-title":"Radiation-induced lung injury: assessment and management","volume":"156","author":"Hanania AN","year":"2019","unstructured":"Hanania AN, Mainwaring W, Ghebre YT, Hanania NA, Ludwig M. Radiation-induced lung injury: assessment and management. Chest. 2019, 156:150-62. 10.1016\/j.chest.2019.03.033","journal-title":"Chest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12041016","article-title":"Diagnosis and management of malignant pleural effusion: a decade in review","volume":"12","author":"Jacobs B","year":"2022","unstructured":"Jacobs B, Sheikh G, Youness HA, Keddissi JI, Abdo T. Diagnosis and management of malignant pleural effusion: a decade in review. Diagnostics (Basel). 2022, 12:1016. 10.3390\/diagnostics12041016","journal-title":"Diagnostics (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/146446-intractable-pleural-effusion-after-stereotactic-ablative-radiotherapy-for-early-stage-lung-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:52Z","timestamp":1707508732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/146446-intractable-pleural-effusion-after-stereotactic-ablative-radiotherapy-for-early-stage-lung-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.36925","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,30]]}}}